Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study

L. Iughetti, G. Tornese, M.E. Street, F. Napoli, C. Giavoli, F. Antoniazzi, Stefano Stagi, Carlo Luongo, Sara Azzolini, L. Ragusa, G. Bona, C. Zecchino, T. Aversa, L. Persani, L. Guazzarotti, Emiliano Zecchi, A. Pietropoli, S. Zucchini

Research output: Contribution to journalArticlepeer-review

Cite this